Centessa Pharmaceuticals (CNTA) Amortizatization of Intangibles (2020 - 2026)

Centessa Pharmaceuticals (CNTA) reported Amortizatization of Intangibles of -$811000.0 for Q1 2026, down 138.95% year-over-year from $2.1 million in Q1 2025, and down 81.43% quarter-over-quarter from -$447000.0 in Q4 2025.

Centessa Pharmaceuticals (CNTA) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Centessa Pharmaceuticals (CNTA) has 3 years of Amortizatization of Intangibles data on file, last reported at -$811000.0 in Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at -$811000.0, down 138.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 152.4% YoY), and the FY2025 annual result was $1.8 million, changed N/A from the prior year.
  • Amortizatization of Intangibles fell to -$811000.0 in Q1 2026 per CNTA's latest filing, from -$447000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $2.1 million in Q1 2025 and troughed at -$811000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Centessa Pharmaceuticals 6.15 Bn 6.15 Bn - -811,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -811,000.00
Mar 31, 2026 -811,000.00
Dec 31, 2025 -447,000.00
Dec 31, 2025 -447,000.00
Sep 30, 2025 114,000.00
Sep 30, 2025 114,000.00
Jun 30, 2025 53,000.00
Jun 30, 2025 53,000.00
Mar 31, 2025 2.08 Mn
Mar 31, 2025 2.08 Mn
Sep 30, 2020 78,000.00
Sep 30, 2020 78,000.00
Jun 30, 2020 72,000.00
Jun 30, 2020 72,000.00